GlassScriptPhysician profile
Anthony Polito
NPI 1205839032
$8,151.62
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,114 · 2020: $37.57.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dne LLC | $7,500.00 | 2019 | |
| Horizon Therapeutics Plc | $384.08 | 2019-2020 | |
| Trilliant Surgical LLC. | $47.97 | 2019 | |
| Zyla Life Sciences, INC. | $47.21 | 2019 | |
| Merck Sharp & Dohme LLC | $46.72 | 2019 | |
| Sebela Pharmaceuticals INC. | $25.47 | 2019 | |
| Integra Lifesciences Corporation | $23.97 | 2019 | |
| Bioventus LLC | $16.33 | 2019 | |
| Polarityte, INC. | $16.14 | 2019 | |
| Osiris Therapeutics INC. | $15.90 | 2019 | |
| Osteomed LLC | $14.71 | 2019 | |
| Smith+Nephew, INC. | $13.12 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Polito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.